| Dr Patricia Helene Burkhart, MD | |
|
2200 Nw Myhre Road, Silverdale, WA 98383-7681 | |
| (360) 830-1101 | |
| (360) 830-1283 |
| Full Name | Dr Patricia Helene Burkhart |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 17 Years |
| Location | 2200 Nw Myhre Road, Silverdale, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376749655 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harrison Medical Center | Bremerton, WA | Hospital |
| Olympic Medical Center | Port angeles, WA | Hospital |
| Jefferson Healthcare | Port townsend, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Olympic Medical Imaging Consultants, Pllc | 8820984552 | 15 |
News Archive
Vivid dreams involving drinking and drug use are common among individuals in recovery. A study from the Massachusetts General Hospital Recovery Research Institute, published in the January issue of the Journal of Substance Abuse Treatment after online release in October 2018, finds these relapse dreams are more common in those with more severe clinical histories of alcohol and other drug problems.
AbleNet announced today the acquisition of TeleConcepts, a company with over 25 years experience and success with direct telephone outreach. Their primary customer base includes professionals who serve the hard of hearing market. AbleNet sees this as an important part of meeting the full needs of individuals with disabilities.
Illumina, Inc. today announced a new price of $19,500 for its individual genome sequencing service. In addition, the company announced a price of $14,500 per genome for groups of five or more participants using the same physician. Individuals with serious medical conditions for whom whole-genome sequencing could provide potential direct clinical value will be eligible for special pricing of $9,500 per genome.
Only a third of homes with a child age 6 or younger and windows on upper stories reported having window guards or locks to keep children from falling out, a new national survey finds.
Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved HETLIOZ (tasimelteon) 20mg capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is the first FDA approved medication for Non-24.
› Verified 2 days ago
| Entity Name | Olympic Medical Imaging Consultants, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750441614 PECOS PAC ID: 8820984552 Enrollment ID: O20040227000417 |
News Archive
Vivid dreams involving drinking and drug use are common among individuals in recovery. A study from the Massachusetts General Hospital Recovery Research Institute, published in the January issue of the Journal of Substance Abuse Treatment after online release in October 2018, finds these relapse dreams are more common in those with more severe clinical histories of alcohol and other drug problems.
AbleNet announced today the acquisition of TeleConcepts, a company with over 25 years experience and success with direct telephone outreach. Their primary customer base includes professionals who serve the hard of hearing market. AbleNet sees this as an important part of meeting the full needs of individuals with disabilities.
Illumina, Inc. today announced a new price of $19,500 for its individual genome sequencing service. In addition, the company announced a price of $14,500 per genome for groups of five or more participants using the same physician. Individuals with serious medical conditions for whom whole-genome sequencing could provide potential direct clinical value will be eligible for special pricing of $9,500 per genome.
Only a third of homes with a child age 6 or younger and windows on upper stories reported having window guards or locks to keep children from falling out, a new national survey finds.
Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved HETLIOZ (tasimelteon) 20mg capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is the first FDA approved medication for Non-24.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia Helene Burkhart, MD 2512 Wheaton Way, Bremerton, WA 98310-3399 Ph: (360) 782-3650 | Dr Patricia Helene Burkhart, MD 2200 Nw Myhre Road, Silverdale, WA 98383-7681 Ph: (360) 830-1101 |
News Archive
Vivid dreams involving drinking and drug use are common among individuals in recovery. A study from the Massachusetts General Hospital Recovery Research Institute, published in the January issue of the Journal of Substance Abuse Treatment after online release in October 2018, finds these relapse dreams are more common in those with more severe clinical histories of alcohol and other drug problems.
AbleNet announced today the acquisition of TeleConcepts, a company with over 25 years experience and success with direct telephone outreach. Their primary customer base includes professionals who serve the hard of hearing market. AbleNet sees this as an important part of meeting the full needs of individuals with disabilities.
Illumina, Inc. today announced a new price of $19,500 for its individual genome sequencing service. In addition, the company announced a price of $14,500 per genome for groups of five or more participants using the same physician. Individuals with serious medical conditions for whom whole-genome sequencing could provide potential direct clinical value will be eligible for special pricing of $9,500 per genome.
Only a third of homes with a child age 6 or younger and windows on upper stories reported having window guards or locks to keep children from falling out, a new national survey finds.
Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved HETLIOZ (tasimelteon) 20mg capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is the first FDA approved medication for Non-24.
› Verified 2 days ago
Ruri Lee, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2916 Nw Bucklin Hill Rd # 381, Silverdale, WA 98383 Phone: 800-841-4236 | |
Dr. Matthew John Hegewald, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 2916 Nw Bucklin Hill Rd Ste 381, Silverdale, WA 98383 Phone: 360-813-6021 | |
Howard N Douds, MD Radiology Medicare: Medicare Enrolled Practice Location: 1780 Nw Myhre Rd, Suite 1220, Silverdale, WA 98383 Phone: 360-337-6500 Fax: 360-337-6523 | |
Robyn B. Vera, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 1900 Nw Myhre Rd, Silverdale, WA 98383 Phone: 564-240-3100 Fax: 360-412-8970 | |
James Wesley Solze Iii, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1780 Nw Myhre Rd, Suite 1220, Silverdale, WA 98383 Phone: 360-337-6500 Fax: 360-337-6523 | |
Dr. Christian Ann Erichsen, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1780 Nw Myhre Rd, Suite 1220, Silverdale, WA 98383 Phone: 360-337-6500 Fax: 360-337-6523 | |
Matthew Shutske, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1780 Nw Myhre Rd, Suite 1220, Silverdale, WA 98383 Phone: 360-337-6500 |